Bristol-Myers Squibb Co (BMY:US)
49.46 +0.14 (+0.28%)
52 WEEK SUMMARY
Mkt Cap 82 B
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.